Related Experiment Video
Updated: Jul 2, 2026

Generation of Organoids from Mouse Extrahepatic Bile Ducts
Published on: April 23, 2019
Organoids in biliary tract cancers: Advances in modeling strategies and translational applications
Xiao-Hu Yang1, Dong-Yang Liu1, Wei Zhao2
1Department of Pediatrics, The General Hospital of Western Theater Command, Chengdu, Sichuan 610083, China.
Biliary organoids offer a powerful 3D in vitro model for studying liver bile duct development and diseases. This review covers their construction, applications in drug screening and personalized medicine for biliary tract cancers (BTCs), and future directions.
Area of Science:
- * Biotechnology and regenerative medicine.
- * Gastroenterology and hepatology research.
Background:
- * Three-dimensional (3D) biliary organoids are an advanced in vitro technology.
- * They are valuable for studying biliary development, disease mechanisms, and drug responses.
- * Applications include personalized medicine and understanding biliary tract cancers (BTCs).
Purpose of the Study:
- * To provide a comprehensive review of current biliary organoid construction strategies.
- * To evaluate their strengths and limitations in modeling biliary physiology and diseases.
- * To analyze challenges and propose future research directions for clinical translation.
Main Methods:
- * Review of existing literature on biliary organoid generation and application.
- * Analysis of cellular sources, differentiation protocols, and functional assessments.
- * Evaluation of organoid utility in disease modeling (especially BTCs) and drug testing.
Main Results:
- * Biliary organoids effectively recapitulate aspects of biliary physiology and disease.
- * Current limitations include modeling efficiency, fidelity, microenvironment simulation, standardization, and ethics.
- * Strengths lie in drug screening, toxicity assessment, and personalized medicine approaches.
Conclusions:
- * Biliary organoids are a versatile tool bridging basic science and clinical applications for BTCs.
- * Future advancements require multicellular co-cultures, dynamic cultivation, and high-throughput platforms.
- * Standardization and ethical considerations are crucial for clinical translation and precision treatment.
More Related Videos
07:25Development and Optimization of A Human Hepatocellular Carcinoma Patient-Derived Organoid Model for Potential Target Identification and Drug Discovery
Published on: August 18, 2023
07:59Portal Vein Injection of Colorectal Cancer Organoids to Study the Liver Metastasis Stroma
Published on: September 3, 2021